StockData
Treace Medical Concepts, Inc. logo

Treace Medical Concepts, Inc. (TMCI) stock

TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3031% below fair value
$4.44+0.02 (+0.45%)

Close on Nov 17, 2026Market cap $288.75MP/E –Yield –

Treace Medical Concepts price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Treace Medical Concepts's price to sales ratio was 1.6× on Nov 11, 2026, against 0.9× a year earlier. Over the last 5 years it ranged from 0.4× to 12.4×, with a median of 3.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.6×+0.9
2025Dec 31, 20250.7×−1.6
2024Dec 31, 20242.3×−2.2
2023Dec 29, 20234.5×−5.7
2022Dec 30, 202210.2×+0.5
2021Dec 31, 20219.7×–

More Treace Medical Concepts figures

See a number that looks wrong?